Loading...

Elixinol Wellness Limited

ELLXF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.02
$-0.00(-0.86%)

Elixinol Wellness Limited (ELLXF) Stock Overview

Explore Elixinol Wellness Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.9/100

Key Financials

Market Cap4.1M
P/E Ratio-2.48
EPS (TTM)$-0.01
ROE-0.20%
Fundamental Analysis

AI Price Forecasts

1 Week$0.00
1 Month$0.01
3 Months$0.00
1 Year Target$0.00

ELLXF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Elixinol Wellness Limited (ELLXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.48 and a market capitalization of 4.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-0.03%
1-Month Change
30.58%
3-Month Change
-38.55%
6-Month Change
-27.45%
Year-to-Date (YTD) Change
-37.32%
1-Year Change
-44.04%
3-Year Change
-94.29%
5-Year Change
-99.21%
All-Time (Max) Change
-99.85%

Contact Information

https://www.elixinolwellness.com
61 2 4044 4585
680 George Street, Sydney, NSW, 2000

Company Facts

IPO DateJun 5, 2018
CountryAU
Actively Trading

Frequently Asked Questions

;